A meta-analysis of controlled clinical trials comparing peginterferon-α plus nucleos(t)ide analogs versus peginterferon-α monotherapy for HBsAg clearance or seroconversion in patients with chronic hepatitis B. [PDF]
Zhu S, Yang Z, Wang Y, Cai X, Qin C.
europepmc +1 more source
Efficacy and Cost-Effectiveness Analyses of Entecavir versus Tenofovir Amibufenamide in Patients with Chronic Hepatitis B. [PDF]
Zeng Y +9 more
europepmc +1 more source
"When the virus ages with the patient": Disease-specific quality of life in individuals with hepatitis B virus infection in Ghana. [PDF]
Oblie FNO +5 more
europepmc +1 more source
No Immediate Need for Nucleos(t)ide Analogs Treatment in Untreated Patients With Low-Level Viremia: Evidence From Hepatitis B Virus RNA Levels. [PDF]
Zhang Y +5 more
europepmc +1 more source
[Comparison of antiviral efficacy of nucleos(t)ide analogue monotherapy and its combination with interferon-α in children 1-6 years-old with HBeAg-positive chronic hepatitis B]. [PDF]
Wang ZW +11 more
europepmc +1 more source
Eight-year Results from Two Randomized Phase 3 Trials of Tenofovir Alafenamide for Chronic Hepatitis B Virus Infection in China. [PDF]
Hou J +23 more
europepmc +1 more source
Long-term HBsAg clearance, relapse, and safety following tenofovir or entecavir discontinuation in non-cirrhotic, HBeAg-negative chronic hepatitis. [PDF]
Sattayalertyanyong O +5 more
europepmc +1 more source
Impact of PC/BCP Mutations on Seroconversion and Relapse in HBeAg-Positive Chronic Hepatitis B Patients Treated with Nucleoside Analogues. [PDF]
Xia S, He X, Gan J, Ding J.
europepmc +1 more source
Liver Transplantation in the World: Present Conditions of Liver Transplantation from Cadaver Donors in USA. [PDF]
Marino, Ignazio Roberto +1 more
core
Circulating HBV RNA and hepatitis B core-related antigen as determinants of HBsAg loss in persons with HIV in Europe. [PDF]
Begré L +18 more
europepmc +1 more source

